Devyser secures a four-year tender in France for Devyser Compact
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
News | August 18, 2022
On September 1, Camilla Wiberg will take up the newly established position as Chief HR Officer (CHRO) and become a member of the Devyser group management. In Devyser’s current growth phase, HR is an important, central function needed to support and develop the organization. Camilla will lead this work in her new role.
Camilla Wiberg has nearly 20 years’ experience working in strategic and operational HR in a number of industries. For the past five years she has run her own company, where she has held various positions including interim HR Manager and organization development roles. She previously worked in HR at companies such as Orkla Care AB and Avanade.
“Camilla has acted as Devyser’s HR Manager on a consultancy basis since autumn 2020 and knows our company and our employees well. We are very pleased that she has chosen to continue to work with us in this new role and we will benefit greatly from her extensive experience working with global growth companies”, says Fredrik Alpsten, Devyser’s CEO.
Following Camilla Wiberg’s appointment, the company’s group management team will comprise Fredrik Alpsten, CEO, Sabina Berlin, CFO, Theis Kipling, CCO, Göran Rydin, COO, Ulf Klangby, Deputy CEO, and Camilla Wiberg, CHRO.
This information was submitted for publication by the contact persons below on 18 August 2022 at 10.30 am CET.
For more information, please contact:
Fredrik Alpsten, CEO
E-mail: fredrik.alpsten@devyser.com
Tel: +46 706 673 106
Sabina Berlin, CFO
E-mail: sabina.berlin@devyser.com
Tel: +46 739 519 502
Link to the official press release:
https://investors.devyser.com/en/press/devyser-appoints-camilla-wiberg-chief-hr-officer-2044197
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More
Devyser is proud to announce that One Lambda Devyser Chimerism and Advyser Chimerism have been...
Read More
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
Read More
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
Read More